BioStock: AdjuTec Pharma joins forces to fight antibiotic resistance

AdjuTec Pharma has launched a research collaboration with India’s Venus Remedies Limited to combat the escalating threat of antimicrobial resistance. With its lead candidate, APC-148, already in phase I trials, AdjuTec aims to breathe new life into – and restore the power of  – existing antibiotics against multidrug-resistant bacteria. This partnership amplifies efforts to address a critical challenge, defined as a global health emergency by the WHO.

Read the article at biostock.se:

https://www.biostock.se/en/2025/03/adjutec-pharma-joins-forces-to-fight-antibiotic-resistance/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/